| 12340-6 |
Ethylene |
PrThr |
Bld |
Pt |
Ord |
|
|
ACTIVE |
Ethylene [Presence] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12340-6 |
|
|
|
|
Both |
|
|
|
0 |
Ethylene Bld Ql |
|
|
|
|
|
Blood; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12341-4 |
Mazindol |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Mazindol [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12341-4 |
|
|
|
|
Both |
|
|
|
0 |
Mazindol SerPl Ql |
|
|
|
|
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Rhotrimine; Sanorex; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12342-2 |
oxyMORphone |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
oxyMORphone [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12342-2 |
|
|
|
|
Both |
|
|
|
0 |
oxyMORphone SerPl Ql |
|
|
|
|
|
14-Hydroxydihydromorphinone; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Numorphan; Numorphone; Opana; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12343-0 |
Thiazides |
Prid |
Urine |
Pt |
Nom |
|
|
ACTIVE |
Thiazides [Identifier] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12343-0 |
|
|
|
|
Both |
|
|
|
0 |
Thiazides Ur |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Identity or presence; Nominal; Point in time; Random; UA; UR; Urn |
2.19 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 12344-8 |
Antipsychotics |
Prid |
Ser/Plas |
Pt |
Nom |
|
|
ACTIVE |
Antipsychotics [Identifier] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12344-8 |
|
|
|
|
Both |
|
|
|
0 |
Antipsychotics SerPl |
|
|
|
|
|
Antipsychotic; DRUG/TOXICOLOGY; Drugs; Identity or presence; neuroleptics; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.15 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 12345-5 |
Cyclothiazide |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Cyclothiazide [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12345-5 |
|
|
|
|
Both |
|
|
|
0 |
Cyclothiazide Ur Ql |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12346-3 |
Methyclothiazide |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Methyclothiazide [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12346-3 |
|
|
|
|
Both |
|
|
|
0 |
Methyclothiazide Ur Ql |
|
|
|
|
|
2-methyl-3-chloromethylhydrochlorothiazide; Aquatensen; C9H11Cl2N3O4S2; DRUG/TOXICOLOGY; Drugs; Enduron; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12347-1 |
metOLazone |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
metOLazone [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12347-1 |
|
|
|
|
Both |
|
|
|
0 |
metOLazone Ur Ql |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Mykrox; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn; Zaroxolyn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12348-9 |
Quinethazone |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Quinethazone [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12348-9 |
|
|
|
|
Both |
|
|
|
0 |
Quinethazone Ur Ql |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12349-7 |
Trichlormethiazide |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Trichlormethiazide [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12349-7 |
|
|
|
|
Both |
|
|
|
0 |
TCM Ur Ql |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; TCM; Triflumen; UA; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 1235-1 |
M little i super little a Ab |
PrThr |
Ser/Plas^BPU |
Pt |
Ord |
|
|
ACTIVE |
Mi sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
1235-1 |
|
|
|
|
Observation |
|
|
|
0 |
Mi sup(a) Ab SerPl BPU Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); i; M (little i) (little a); Mi sup(a); Mi^a; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPl^bpu; SerPlas; Serum; Serum or plasma; SR |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12350-5 |
Amphetamines |
PrThr |
Stool |
Pt |
Ord |
|
|
ACTIVE |
Amphetamines [Presence] in Stool |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12350-5 |
|
|
|
|
Both |
|
|
|
0 |
Amphetamines Stl Ql |
|
|
|
|
|
Addiction; Amph; Amphetam; Amphetamine; Bowel movement; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Faecal; Faeces; Fecal; Feces; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Speed; Stl; Stool = Fecal |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12351-3 |
Tetrahydrocannabinol |
PrThr |
Stool |
Pt |
Ord |
|
|
ACTIVE |
Tetrahydrocannabinol [Presence] in Stool |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12351-3 |
|
|
|
|
Both |
|
|
|
0 |
THC Stl Ql |
|
|
|
|
|
Bowel movement; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Dronabinol; DRUG/TOXICOLOGY; Drugs; Faecal; Faeces; Fecal; Feces; Marijuana; Nabilone; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal; THC |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12352-1 |
Benzoylecgonine |
PrThr |
Stool |
Pt |
Ord |
|
|
ACTIVE |
Benzoylecgonine [Presence] in Stool |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12352-1 |
|
|
|
|
Both |
|
|
|
0 |
BZE Stl Ql |
|
|
|
|
|
BEC; BEG; Benz; Benzoylec; Bowel movement; BZE; Cocaine degradation production; Cocaine metabolite; Crack metabolite; DRUG/TOXICOLOGY; Drugs; Faecal; Faeces; Fecal; Feces; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12353-9 |
Methaqualone |
PrThr |
Stool |
Pt |
Ord |
|
|
ACTIVE |
Methaqualone [Presence] in Stool |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12353-9 |
|
|
|
|
Both |
|
|
|
0 |
Methaqualone Stl Ql |
|
|
|
|
|
Addiction; Bowel movement; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Faecal; Faeces; Fecal; Feces; Illicit; Methaqualon; Ordinal; Point in time; PotentialForAbuse; PR; QL; Quaalude; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12354-7 |
Opiates |
PrThr |
Stool |
Pt |
Ord |
|
|
ACTIVE |
Opiates [Presence] in Stool |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12354-7 |
|
|
|
|
Both |
|
|
|
0 |
Opiates Stl Ql |
|
|
|
|
|
Addiction; Bowel movement; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Faecal; Faeces; Fecal; Feces; Heroin; Illicit; OP; Opi; Opiate; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12355-4 |
Phencyclidine |
PrThr |
Stool |
Pt |
Ord |
|
|
ACTIVE |
Phencyclidine [Presence] in Stool |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12355-4 |
|
|
|
|
Both |
|
|
|
0 |
PCP Stl Ql |
|
|
|
|
|
Addiction; Angel dust; Bowel movement; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Faecal; Faeces; Fecal; Feces; Illicit; Ordinal; PCP; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Sernylan; Stl; Stool = Fecal |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12356-2 |
Methadone |
PrThr |
Stool |
Pt |
Ord |
|
|
ACTIVE |
Methadone [Presence] in Stool |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12356-2 |
|
|
|
|
Both |
|
|
|
0 |
Methadone Stl Ql |
|
|
|
|
|
Addiction; Bowel movement; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Faecal; Faeces; Fecal; Feces; Illicit; METD; Methadose; MTD; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12357-0 |
Propoxyphene |
PrThr |
Stool |
Pt |
Ord |
|
|
ACTIVE |
Propoxyphene [Presence] in Stool |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12357-0 |
|
|
|
|
Both |
|
|
|
0 |
Propoxyph Stl Ql |
|
|
|
|
|
Addiction; Algaphan; Bowel movement; Cosalgesic; Cotonal-65; Darvon; Depronal; Dextrogesic; Dextropropoxyphene; Distalgesic; Dolasan; Doloxene; D-propoxyphene; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Faecal; Faeces; Fecal; Feces; Illicit; Napsalgesic; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12358-8 |
Barbiturates |
PrThr |
Stool |
Pt |
Ord |
|
|
ACTIVE |
Barbiturates [Presence] in Stool |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12358-8 |
|
|
|
|
Both |
|
|
|
0 |
Barbiturates Stl Ql |
|
|
|
|
|
Addiction; Barb; Barbiturate; Barbs; Bowel movement; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Faecal; Faeces; Fecal; Feces; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12359-6 |
Benzodiazepines |
PrThr |
Stool |
Pt |
Ord |
|
|
ACTIVE |
Benzodiazepines [Presence] in Stool |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12359-6 |
|
|
|
|
Both |
|
|
|
0 |
Benzodiaz Stl Ql |
|
|
|
|
|
Benz; Benzodiaz; Benzodiazepine; Bowel movement; DRUG/TOXICOLOGY; Drugs; Faecal; Faeces; Fecal; Feces; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 1236-9 |
M little i super little a Ab |
PrThr |
Ser/Plas^Donor |
Pt |
Ord |
|
|
ACTIVE |
Mi sup(a) Ab [Presence] in Serum or Plasma from Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
1236-9 |
|
|
|
|
Observation |
|
|
|
0 |
Mi sup(a) Ab SerPl Donr Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Donr; i; M (little i) (little a); Mi sup(a); Mi^a; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12360-4 |
Barbital |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Barbital [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12360-4 |
|
|
|
|
Both |
|
|
|
0 |
Barbital Ur Ql |
|
|
|
|
|
Addiction; Barbitone; Barbiturate; Diethylmalonylurea; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Megal; Neurinase; Ordinal; Pneumogeine-barbital; Point in time; PotentialForAbuse; PR; Provervon n; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn; Veraine buriat; Veronal; Vitanerton N Kerne |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12361-2 |
Oxazepam |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Oxazepam [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12361-2 |
|
|
|
|
Both |
|
|
|
0 |
Oxazepam Ur Ql |
|
|
|
|
|
Alepam; Chlordiazepoxide metabolite; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; Prazepam metabolite; QL; Qual; Qualitative; Random; Screen; Serax; Temazepam metabolite; UA; UniversalLabOrders; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12362-0 |
Oxazepam |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Oxazepam [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12362-0 |
|
|
|
|
Both |
|
|
|
0 |
Oxazepam SerPl Ql |
|
|
|
|
|
Alepam; Chlordiazepoxide metabolite; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; Prazepam metabolite; QL; Qual; Qualitative; Random; Screen; Serax; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Temazepam metabolite |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
